Interaction of Quinidine with Anticonvulsant Drugs
NEJM 294:699, Data,J.L.,et al, 1976
Myasthenia Gravis Assoc. with Wasp Sting
JAMA 235:2120, Brumlik,J., 1976
IgA Deficiency and Systemic Lupus Erythematosus
Arch Dermatol 112:845-849, Takigawa,M.,et al, 1976
Recent Observations on Central Nervous System Lupus Erythematosus
Seminars in Arth & Rheum 4:253975., Bennahum,D., 1975
Diphenylhydantoin & Selected Congenital Malformations
NEJM 289:1049, 1973; 289:1089973., Monson,R.,et al, 1973
Teratogenic Effect of Anticonvulsnats
Lancet 198, 1973 Jan., , 1973
Neurologic Manifestations of SLE 1972
Nebraska State Journ Med, Oct 1972, pp 395., Aita,J., 1972
Maternal Epilepsy & Abnormalities of the Fetus & Newborn
Lancet 839, Oct1972., Speidel,B.,et al, 1972
Untoward Effects of Anticonvulsants
NEJM 286:1316, Kutt,H., 1972
Effect of Chronic Anticonvulsant Therapy on Serum 25-Hydroxycalciferol Levels in Adults
NEJM 287:898, Hahn,T.,et al, 1972
Megaloblastic Anemia After Anticonvulsive Therapy
Corres, NEJM 287:9901972., , 1972
Case Record of MGH-NEJM Subdural Hematoma Secondary to Metastasis & Lacunar Infarcts
286:650, , 1972
Coarse Facies, Calvarial Thickening & Hyperphosphatasia Associated with Long-Term Anticonvulsant Therapy
NEJM 286:1301, 1972; 287:721972., Lefebvre,E.,et al, 1972
Coagulation Defects Caused by Diphenylhydantoin
Neurol 22:1165-1171, Solomon,G.E.,et al, 1972
Drug-Induced Neurologic Disorders in Childhood
Current Problems in Pediatrics 1:1, Schwartz,J., 1971
Diphenylhydantoin Intoxication & Cerebrospinal Fluid Protein
Neurol 18:1009-1011, Rawson,M.D., 1968
Diphenylhydantoin Activated Seizures
Neurol 15:716-722, Levy,L.L.,et al, 1965
Unusual Brain Syndrome Seen with Diphenylhydantoin & Phenobarbitol
Am J Psych 120:282-283, Hoaken,P.C.S.,et al, 1963
Dilantin Toxicity
Neurol 11:912-922, Roseman,E., 1961
Abducens Nerve Palsy in Dilantin Intoxication
J Pediatr 55:73-77, Manlapaz,J.S., 1959
Zorevunersen in Children and Adolescents with Dravet Syndrome
NEJM 394:969-982, Laux,L.,et al, 2026
Using Susceptibility-Based Imaging in Highly Active Late-Onset Multiple Sclerosis
Neurol 106:e214794, Sosa,S.M.,et al, 2026
Paramagnetic Rim Lesions and Development of Clinical MS in Radiologically Isolated Syndrome
JAMA Neurol 83:250-258, Lim,T.R.et al, 2026
Iatrogenic Cerebral Amyloid Angiopathy after Cardiac Surgery, Two Case Reports
Neurol 106:e214819, Brunet de Courssou,J-B.,et al, 2026
Clinical Manifestations of Primary CNS T-Cell Lymphoma, Retrospective Study of Histopathologic, Molecular, and Neuroimaging Fetures
Neurol 106:e24744, Muller,K.J.,et al, 2026
The 2024 McDonld Criteria for Dignosis of Multiple Sclerosis, The Rubber meets the Road
Neurol 106:e214688, Miller, A.E., 2026
Patterns and Factors Associated with Cerebral Infarction on MRi in Tuberculous Meningitis: Secondary Anlysis of the ACT-TBM Trial
Stroke 57:856-864, Chandu,M.,et al, 2026
A 67-Year-Old Man with Exercise Intolerance nd Progressive Weakness
Neurol 106:e214830, Gosset,A.,et al, 2026
Left Atrial Appendage Closure - Another Overused Method in Cardiology?
NEJM 394:1336-1338, Widimsky,P, 2026
Using Susceptibility-Based Imaging in highly ctive Late-Onset Multiple Sclerosis
Neurol 106:e214794, Sosa,S.M.,et al, 2026
Asundexian for Secondary Stroke Prevention
NEJM 394:1467-1479, 1540, Sharm,M.,et al, 2026
Large Language Model Performance and Clinical Reasoning Tasks
JAMA Netw Open 9:e264003, Rao,A.S.,et al, 2026
Status Epilepticus After Carotid Endarterectomy:An Illustrative Case of Cerebral Hyperfusion Syndrome
Stroke 57:e188-191, Reuter,P.,et al, 2026
Glucagon-like Peptide-1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy
Neurol 106:e214864, Dhivagaran,T.,et al, 2026
Endovascular Venous Sinus Stenting versus CSF Shunting for Idiopathic Intracranial Hypertssion:Nationwide Real-World Outcomes
AJNR 47:1238-1243, Chen,H.,et al, 2026
Peripheral Neuropathy, A Review
JAMA 335:255-266, Mauermann,M.L. & Staff,N.P., 2026
Disseminated Brain Infarcts Associated with Uterine Myoma
Stroke 57:e61-e62, Elbischger,J.,et al, 2026
Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After IschemicStroke, The OPTION Randomized Clinical Trial
JAMA doi:10.1001/JAMA.2026.0210, Ma,G.,et al, 2026
A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion
NEJM 394:442-450, Ryan,S.J.,et al, 2026
Treatment for Brain Metastases with Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation, A Randomzid Clinical Trial
JAMA doi.10.1001/JAMA.2026.0076;2026, Aizer,A.A.,et al, 2026
Intranasal Selectracetam in a Patient with Reading Epilepsy:First-In-Human Use to Prevent Reflex Seizures
Ann Neurol 99:535-539, Koepp,M.J.,et al, 2026
A Woman with Parkinson Disease, Dyskinesia, Rhadomyolysis, Subcutaneous Emphysema, and Pneumomediastinum
Neurol 106:e218064, Iqbal,M.M.,et al, 2026
Safety and Outcomes of Dibigatran Reversal with Idarucizumab Before IV Thrombolysis in Patients with Acute Ischemic Stroke
Neurol 106:e218012, Saflund,M.,et al, 2026
Melas Syndrome
Stat PearlsPubl Jan 25, Pia,S. & Lui,F., 2025
High-Grade Gliomas with Autoimmune Encephalitis-Like Presentation: Case Report and Systematic Review of the Literature
Neurological Sci 46:3559-3572, Creda,G.S.et al, 2025
Wearable Technology and Its Role in Neurologic Care, Emerging Issues in Neurology
Neurol 106:e214802, Benish,S.M.,et al, 2025
Timing and Safety of Anticoagulation Reinitiation After Intracranial Hemorrhage in Patients with Mechanical Valves
Neurol 105:e214184, DAnna,L.,et al, 2025
Intravenous Thrombolysis Use Before Inter-Facility Transfer for Thrombectomy:Association with Efficacy and Safety Outcomes
Ann Neurol 98:871-880, Seners,P.,et al, 2025
Addressing Systemic Complications of Acute Stroke: A Scientific Statement From the American Heart Association
Stroke 56:e15-e29, Kumar,S.,et al, 2025
Effectiveness and Safety of IV Thrombolysis Before Hospital Transfer for Thrombectomy in Patients With Basilar Artery Occlusion
Neurol 105:e214355, Liebart,S.,et al, 2025